Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy

Angela Dispenzieri

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy'. Together they form a unique fingerprint.